Fisher & Paykel Healthcare Corporation Limited (FPH.NZ) Stock

FPH.NZ logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZNew Zealand
Healthcare

Company profile

Fisher & Paykel Healthcare reported revenue of 1.28 billion NZD for fiscal year 2025, and net income of 377.20 million NZD. That is a net profit margin of 29.5% for fiscal year 2025. North America was its largest region in fiscal year 2025, with 48% of revenue. Our analysis of its filings shows revenue shrinking from 1.59 billion NZD in fiscal year 2023 to 1.28 billion NZD in fiscal year 2025, 10.2% a year on average. Fisher & Paykel Healthcare reports about 7,357 full-time employees.

What stands out

  • Revenue fell 27.2% in fiscal year 2025, from 1.76 billion NZD in fiscal year 2024, after a rise of 10.7% the year before.
  • Net income more than doubled in fiscal year 2025, from 132.60 million NZD in fiscal year 2024.

Figures from company filings; latest fiscal year ended March 31, 2025.

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Largest shareholders

  • Australiansuper Pty Ltd. (Investment Management)7.06%
  • Pinnacle Investment Management Group Limited5.01%
  • Hyperion Asset Management Ltd.4.97%
  • BlackRock Fund Advisors3.40%
  • Guardians of New Zealand Superannuation2.55%

Share of the company, as of September 25, 2026

Leadership

  • Lewis G. Gradon — MD, CEO & Executive Director, 64
  • Lyndal York — Chief Financial Officer
  • Andy Niccol — Chief Operating Officer
  • Andrew Somervell — Vice President of Products & Technology
  • Daniel Adolph — Head of Investor Relations

How much revenue does Fisher & Paykel Healthcare make?

Fisher & Paykel Healthcare reported 1.28 billion NZD in revenue for fiscal year 2025, down 27.2% from 1.76 billion NZD in fiscal year 2024.

Where does Fisher & Paykel Healthcare make most of its revenue?

North America: 48% of revenue by region in fiscal year 2025, followed by Europe (27%).

How has Fisher & Paykel Healthcare's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 1.95 billion NZD; FY2022, 1.64 billion NZD; FY2023, 1.59 billion NZD; FY2024, 1.76 billion NZD; FY2025, 1.28 billion NZD.

Has Fisher & Paykel Healthcare made a profit in recent years?

Net income by fiscal year: FY2021, 524.20 million NZD; FY2022, 376.90 million NZD; FY2023, 250.30 million NZD; FY2024, 132.60 million NZD; FY2025, 377.20 million NZD. It was profitable in each of these years.

Company Information

SectorHealthcare
IndustryTargeted Healthcare Equipment
Employees7,357
Founded1971
IPO DateNov 1, 1979
IPO StatusPublic
HeadquartersAuckland, New Zealand
FoundersMaurice Paykel, Woolf Fisher
ExchangeNZSE
TimezonePacific/Auckland (NZDT)

Contact & Links

Address
15 Maurice Paykel Place, Auckland, 2013
Phone
64 9 574 0100
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/FPH.NZ

LinkedInLinkedInXXYouTubeYouTube